Reading Response Paper – Reproductive Issues and Prenatal Life
Insight 1: Healthcare Professionals Should Work Collaboratively with Regulatory Agencies
to Regulate Preimplantation Genetic Diagnosis
A.
Before embryos are implanted into a woman’s uterus, preimplantation genetic diagnosis
(PGD), a process frequently employed during IVF, checks them for any potential problems
(Bayefsky, 2018). Its primary goal was to lower the likelihood that children conceived through
IVF would contract hereditary illnesses and abnormalities. However, controversy surrounding
this medical process has been linked to the fact that some healthcare practitioners give PDG
treatments with sex selection as their major focus. Statistics show that 83.5 percent of US
fertility clinics that provide sex selection services also provide those treatments to viable
couples, out of the 73.7 percent of those clinics that do so (Bayefsky, 2018). These organizations
eventually compromise the integrity of medical practice.
B.
As well, additional concerns have been raised regarding the use of PDG. This concern
includes the likelihood that these clinics may choose a child’s physical characteristics, such as
height, hair color, and an athletic build (Bayefsky, 2018). The achievement of non-medical goals
enhances the requirement for PGD regulation. The healthcare organizations and experts should
work together with the regulatory bodies to ensure that this service is under control. While
healthcare providers should print out this charter and post it on notice boards to raise awareness
of the restrictions, the government and professional organizations should adopt policies on the
particular situations that should be covered by the PGD plan.
C.
The only embryos that will result in the birth of a healthy kid are those that do not have
any chromosomal abnormalities. As such, PGS procedures allow us to choose reproductively
